These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28922344)

  • 21. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
    Senin U; Cherubini A; Palumbo B; Mecocci P
    Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
    [No Abstract]   [Full Text] [Related]  

  • 27. Patient education series. Alzheimer's disease.
    Nursing; 2007 Jun; 37(6):50-1. PubMed ID: 17538443
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapies for Alzheimer's disease.
    Melnikova I
    Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055
    [No Abstract]   [Full Text] [Related]  

  • 29. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UK government guidance on Alzheimer's drugs postponed.
    O'Neill MF
    Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of Alzheimer disease.
    Winslow BT; Onysko MK; Stob CM; Hazlewood KA
    Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 33. Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics.
    Rainer M; Mucke HA; Krüger-Rainer C; Kraxberger E; Haushofer M; Jellinger KA
    J Neural Transm (Vienna); 2001; 108(11):1327-33. PubMed ID: 11768631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
    Aisen PS
    J Am Acad Nurse Pract; 2005 Mar; Suppl():5-7. PubMed ID: 16033023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological and non-pharmacological treatment of Alzheimer's dementia].
    Wallesch CW
    MMW Fortschr Med; 2013 May; 155(8):60-2. PubMed ID: 24437141
    [No Abstract]   [Full Text] [Related]  

  • 37. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in the treatment of Alzheimer's disease.
    Schneider LS
    Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
    [No Abstract]   [Full Text] [Related]  

  • 39. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 40. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.